维普中文期刊产品整合服务
63篇 您的检索式:作者名="PETRIKKOS G"
    题名 作者 年代 出处 被引量
1Differences in the changes in resistance patterns to third-and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital显示文摘Petrikkos G Markogiannakis A Papapareskevas J 2007Int J Antimicrob Agents2007,29,1:1
2Prevalence of methicillin resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers显示文摘Tentolouris N Petrikkos G Vallianou N 2006Clin Microbiol Infect2006,12,2:1
3Mucormyeosis: ten-year experience at a tertiary-care center in Greece 显示文摘PETRIKKOS G SKIADA A SAMBATAKOU H 2003Eur J Clin Microbiol Infect Dis2003,22,12:1
4Prevalenceof methicillin resistant staphy lococcus aureus in infectedand uninfected diabetic foot ulcers显示文摘Tentolouris N Petrikkos G Vallianou N 2006Clin Mjcmbiol In-fect2006,12,2:1
5Recent advances in antifungal chemotherapy显示文摘Petrikkos G Skiada A 2007International Journal of Antimicrobial Agents2007,30,:1
6Efficacy an safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy 显示文摘Maertens J Raad I Petrikkos G 2004Clin Infect Dis2004,39,11:1
7Activity of intracellular antibiotics infection显示文摘 Prinz G Petrikkos G 1991J Antimicrob Chemother1991,19,4:1
8Assessment of prealbumm in hemodialysis and renal-transplant patients显示文摘Chrysostomou S Stathakis C Petrikkos G 2010J Ren Nutr2010,20,1:1
9Recent advances in antifungal chemothera- py显示文摘Petrikkos G Skiada A 2007Intl J Antimicrob Agents2007,30,:1
10Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy 显示文摘Maertens J Raad I Petrikkos G 2004Clin Infect Dis2004,39,11:1
11Prevalence of methicillin-resistant staphylococcus aureus in infected and uninfected diabetic foot ulcers显示文摘Tentolouris N Petrikkos G Vallianou N 2006Clin Mjcmbiol Infect2006,12,2:1
12Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy显示文摘Maertens J Raad I Petrikkos G 2004Clin Infect Dis2004,39,:1
13Recent advances in antifungal chemother-apy显示文摘Petrikkos G Skiada A 2007Int J Antimicrob Agents2007,30,2:1
14PCR versus culture in the detection of vaginal Ureaplasma urealyticum and Mycoplasma hominis显示文摘PETRIKKOS G L HADJISOTERIOU M DAIKOS G L 2007International Journal of Gynecology & Obstetrics2007,97,3:1
15Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy 显示文摘Maertens J Raad I Petrikkos G 2004Clinlnfect Dis2004,39,11:1
16Epidemiology and Clinical Manifestationsof Mucormycosis 显示文摘Petrikkos G Skiada A Lortholary O 2012Clin Infect Dis2012,54,1:1
17Prospective observational study of the impact of VIM - 1 metallo - lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections 显示文摘Daikos G L P Petrikkos M Psichogiou C 2009Antimicrob Agents Chemother2009,53,:1
18Encironmental surveillance of filamentous fungi in three tertiary care hospitals in Greece 显示文摘Panagopoulou P Filioti J Petrikkos G 2002J Hosp Infect2002,52,3:1
19Spread of integron-associated VIM-type metallo-beta-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals显示文摘GIAKKOUPI P PETRIKKOS G TZOUVELEKIS L S 2003J Clin Microbiol2003,41,2:1
20Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy显示文摘Maertens J Raad I Petrikkos G 2004Clin Infect Dis2004,39,11:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费